CLINICAL_TRIALS trial_result · 2019-06-25

Clinical Trial Update: "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA" [Phase 3]

Phase 3 long-term safety study of JZP-110 in narcolepsy and obstructive sleep apnea has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Jazz Pharmaceuticals | Conditions: Narcolepsy, Obstructive Sleep Apnea | Phase 3 | Status: COMPLETED | Results posted: 2019-06-25